MAXIMUS, Inc. (NYSE:MMS) – Equities research analysts at KeyCorp lowered their FY2018 EPS estimates for MAXIMUS in a research report issued to clients and investors on Wednesday. KeyCorp analyst J. Gurda now expects that the health services provider will earn $3.22 per share for the year, down from their previous estimate of $3.33. KeyCorp currently has a “Sector Weight” rating on the stock. KeyCorp also issued estimates for MAXIMUS’s FY2019 earnings at $3.52 EPS.
MMS has been the subject of several other research reports. Jefferies Group LLC reiterated a “buy” rating and set a $64.00 target price (down previously from $65.00) on shares of MAXIMUS in a research report on Thursday, February 16th. ValuEngine lowered MAXIMUS from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. Canaccord Genuity reissued a “buy” rating and set a $62.00 price target on shares of MAXIMUS in a research note on Friday, April 7th. Maxim Group lowered MAXIMUS from a “buy” rating to a “hold” rating and set a $66.00 price target for the company. in a research note on Thursday, May 4th. They noted that the move was a valuation call. Finally, Zacks Investment Research lowered MAXIMUS from a “hold” rating to a “sell” rating in a research note on Friday, February 10th. One analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. MAXIMUS has an average rating of “Hold” and a consensus price target of $61.33.
WARNING: This story was posted by BBNS and is the sole property of of BBNS. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://baseballnewssource.com/markets/brokers-issue-forecasts-for-maximus-inc-s-fy2018-earnings-mms-updated-updated/862447.html.
Shares of MAXIMUS (NYSE:MMS) opened at 62.40 on Friday. The company has a market cap of $4.04 billion, a P/E ratio of 20.46 and a beta of 1.13. The stock’s 50 day moving average price is $61.28 and its 200-day moving average price is $58.35. MAXIMUS has a 12 month low of $43.69 and a 12 month high of $64.25.
MAXIMUS (NYSE:MMS) last issued its quarterly earnings results on Thursday, May 4th. The health services provider reported $0.80 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.78 by $0.02. The firm had revenue of $622 million during the quarter, compared to the consensus estimate of $620.24 million. MAXIMUS had a return on equity of 26.42% and a net margin of 8.08%. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter last year, the company posted $0.74 EPS.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 31st. Investors of record on Monday, May 15th will be paid a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date is Thursday, May 11th. MAXIMUS’s dividend payout ratio is currently 5.98%.
In related news, President Bruce Caswell sold 17,197 shares of the firm’s stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $62.47, for a total transaction of $1,074,296.59. Following the completion of the sale, the president now directly owns 27,904 shares of the company’s stock, valued at approximately $1,743,162.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Russell A. Beliveau sold 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $63.82, for a total value of $95,730.00. Following the sale, the director now directly owns 41,829 shares of the company’s stock, valued at $2,669,526.78. The disclosure for this sale can be found here. Insiders have sold a total of 126,407 shares of company stock valued at $7,839,076 over the last three months. 3.10% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MMS. HighTower Advisors LLC increased its position in MAXIMUS by 35.1% in the first quarter. HighTower Advisors LLC now owns 6,879 shares of the health services provider’s stock valued at $426,000 after buying an additional 1,788 shares during the last quarter. Ranger Investment Management L.P. increased its position in MAXIMUS by 3.7% in the first quarter. Ranger Investment Management L.P. now owns 599,499 shares of the health services provider’s stock valued at $37,289,000 after buying an additional 21,249 shares during the last quarter. AQR Capital Management LLC increased its position in MAXIMUS by 0.9% in the first quarter. AQR Capital Management LLC now owns 40,868 shares of the health services provider’s stock valued at $2,542,000 after buying an additional 361 shares during the last quarter. State Street Corp increased its position in MAXIMUS by 2.5% in the first quarter. State Street Corp now owns 2,066,226 shares of the health services provider’s stock valued at $128,517,000 after buying an additional 50,670 shares during the last quarter. Finally, Bank of America Corp DE increased its position in MAXIMUS by 1.0% in the first quarter. Bank of America Corp DE now owns 390,232 shares of the health services provider’s stock valued at $24,273,000 after buying an additional 3,914 shares during the last quarter. Institutional investors own 98.74% of the company’s stock.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for MAXIMUS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS Inc. and related companies with our FREE daily email newsletter.